carbidopa — Medica
Postencephalitic parkinsonism
Initial criteria
- Patient is currently receiving carbidopa/levodopa therapy
- Medication is prescribed by or in consultation with a neurologist
Reauthorization criteria
- Patient continues to meet initial criteria
Approval duration
1 year